scholarly article | Q13442814 |
P356 | DOI | 10.1158/1535-7163.MCT-13-0651 |
P8608 | Fatcat ID | release_26236nvmvffvhg2gese425ci2a |
P932 | PMC publication ID | 3954431 |
P698 | PubMed publication ID | 24356816 |
P5875 | ResearchGate publication ID | 259394989 |
P50 | author | Giuseppe Fiume | Q56935184 |
Francesco P. D'Armiento | Q58379134 | ||
Cristina Capuano | Q60447892 | ||
Angela Santoni | Q62560406 | ||
Patrizia Bonelli | Q87578401 | ||
Antonio Barbieri | Q39050494 | ||
Claudio Arra | Q39050534 | ||
Camillo Palmieri | Q42857716 | ||
P2093 | author name string | Massimo Mallardo | |
Fabrizio Dal Piaz | |||
Franco Maria Buonaguro | |||
Marco Schiavone | |||
Giuseppe Scala | |||
Ileana Quinto | |||
David Venzon | |||
Enrico Iaccino | |||
Annamaria de Laurentiis | |||
Cristina Falcone | |||
Franca Maria Tuccillo | |||
Ricciarda Galandrini | |||
Iris Scala | |||
P2860 | cites work | Mimotope vaccination--from allergy to cancer | Q24608624 |
Inhibition of HIV-1 replication in primary human monocytes by the IkappaB-alphaS32/36A repressor of NF-kappaB | Q24802730 | ||
CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes | Q28141639 | ||
Molecular mimics of the tumour antigen MUC1 | Q28485169 | ||
Biology of natural killer cells | Q29619728 | ||
Identification of the human melanoma-associated chondroitin sulfate proteoglycan antigen epitope recognized by the antitumor monoclonal antibody 763.74 from a peptide phage library. | Q30637602 | ||
Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes | Q30760776 | ||
Allergen mimotopes | Q31047676 | ||
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model | Q32145219 | ||
Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu | Q33204113 | ||
Purification and characterization of a human sialoglycoprotein antigen expressed in immature thymocytes and fetal tissues | Q47809701 | ||
Computational analysis and in vivo validation of a microRNA encoded by the IBTK gene, a regulator of B-lymphocytes differentiation and survival. | Q52839180 | ||
UN1, a murine monoclonal antibody recognizing a novel human thymic antigen. | Q53382298 | ||
The Roman god Janus: a paradigm for the function of CD43 | Q57220718 | ||
Differential expression of UN1, early thymocyte-associated sialoglycoprotein, in breast normal tissue, benign disease and carcinomas | Q74602404 | ||
Fetal ontogeny and tumor expression of the early thymic antigen UN1 | Q77764350 | ||
IkappaB-alpha represses the transcriptional activity of the HIV-1 Tat transactivator by promoting its nuclear export | Q81453447 | ||
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ | Q83830331 | ||
Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules | Q85945841 | ||
High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells | Q33209339 | ||
Matching of trastuzumab (Herceptin) epitope mimics onto the surface of Her-2/neu--a new method of epitope definition | Q33214024 | ||
A novel method to identify and characterise peptide mimotopes of heat shock protein 70-associated antigens. | Q33239312 | ||
Mimotope vaccines for cancer immunotherapy | Q33271867 | ||
Immunization with mimotopes prevents growth of carcinoembryonic antigen positive tumors in BALB/c mice | Q33304623 | ||
Cancer vaccine with mimotopes of tumor-associated carbohydrate antigens | Q33504695 | ||
Progress in phage display: evolution of the technique and its application | Q33536051 | ||
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder. | Q33549106 | ||
Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response | Q33591326 | ||
Identification of PSA peptide mimotopes using phage display peptide library | Q33888771 | ||
Monoclonal antibodies: versatile platforms for cancer immunotherapy | Q34111693 | ||
Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity | Q34324528 | ||
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. | Q34432286 | ||
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-κB. | Q34776278 | ||
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein | Q34994374 | ||
Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65. | Q35906138 | ||
Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide | Q35987717 | ||
Design and characterization of a peptide mimotope of the HIV-1 gp120 bridging sheet | Q36057328 | ||
Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities | Q36671737 | ||
Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk | Q36798706 | ||
More than one reason to rethink the use of peptides in vaccine design | Q36808693 | ||
The safety and side effects of monoclonal antibodies | Q37715703 | ||
Awaiting a new era of cancer immunotherapy | Q38027832 | ||
Monoclonal antibodies in oncology therapeutics: present and future indications | Q38071374 | ||
PIP2-dependent regulation of Munc13-4 endocytic recycling: impact on the cytolytic secretory pathway | Q39407350 | ||
Tumor suppressor p53 down-regulates expression of human leukocyte marker CD43 in non-hematopoietic tumor cells | Q39468183 | ||
Changes in the gene expression profile of gastric cancer cells in response to ibuprofen: a gene pathway analysis | Q39693012 | ||
Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies | Q40351380 | ||
Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu | Q40619387 | ||
Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). | Q40844552 | ||
Structural and functional insights into IκB-α/HIV-1 Tat interaction | Q46174335 | ||
P433 | issue | 3 | |
P921 | main subject | immunotherapy | Q1427096 |
P304 | page(s) | 752-762 | |
P577 | publication date | 2013-12-19 | |
P1433 | published in | Molecular Cancer Therapeutics | Q2363144 |
P1476 | title | Cancer-associated CD43 glycoforms as target of immunotherapy | |
P478 | volume | 13 |
Q64999316 | Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B-cell lymphoma. |
Q64039325 | Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia |
Q37565369 | Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells |
Q35969225 | Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis |
Q64062562 | Hexosamine Biosynthetic Pathway and Glycosylation Regulate Cell Migration in Melanoma Cells |
Q38440482 | IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells. |
Q36032171 | Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice |
Q42377367 | Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes. |
Q36300374 | N-Glycan matrix-assisted laser desorption/ionization mass spectrometry imaging protocol for formalin-fixed paraffin-embedded tissues. |
Q37010993 | OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations |
Q89777243 | Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in mice |
Q89782282 | Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy |
Q59808943 | Revisiting Bacterial Ubiquitin Ligase Effectors: Weapons for Host Exploitation |
Q92471875 | The Ubiquitin-proteasome pathway regulates Nectin2/CD112 expression and impairs NK cell recognition and killing |
Q91292054 | Unconventional secretion of α-Crystallin B requires the Autophagic pathway and is controlled by phosphorylation of its serine 59 residue |
Q38709753 | Unraveling the Receptor-Ligand Interactions between Bladder Cancer Cells and the Endothelium Using AFM. |
Search more.